company background image
AVNS logo

Avanos Medical NYSE:AVNS Stock Report

Last Price

US$19.91

Market Cap

US$858.9m

7D

2.2%

1Y

-30.7%

Updated

28 Mar, 2024

Data

Company Financials +

AVNS Stock Overview

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

AVNS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Avanos Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Avanos Medical
Historical stock prices
Current Share PriceUS$19.91
52 Week HighUS$31.31
52 Week LowUS$17.24
Beta0.95
1 Month Change2.95%
3 Month Change-11.24%
1 Year Change-30.72%
3 Year Change-55.34%
5 Year Change-54.58%
Change since IPO-49.91%

Recent News & Updates

Recent updates

Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Jan 05
Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

Aug 14
Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Aug 13
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy

Jul 16

We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Jun 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

May 18
Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

May 07
Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Mar 02
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Avanos Medical Q4 2022 Earnings Preview

Feb 20

Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Feb 10
Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Jan 13
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance

Nov 02

Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate

Sep 12

Avanos Medical Q2 2022 Earnings Preview

Aug 08

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

May 28
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

May 03
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Feb 10
Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

Dec 21
Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Nov 04
An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

Sep 10
Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Aug 10
The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

Jun 30
Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

Jun 09
We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

Avanos Medical Q1 2021 Earnings Preview

May 06

Estimating The Fair Value Of Avanos Medical, Inc. (NYSE:AVNS)

Feb 03
Estimating The Fair Value Of Avanos Medical, Inc. (NYSE:AVNS)

Avanos Medical, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 09

Shareholder Returns

AVNSUS Medical EquipmentUS Market
7D2.2%2.2%0.4%
1Y-30.7%13.3%28.8%

Return vs Industry: AVNS underperformed the US Medical Equipment industry which returned 13.3% over the past year.

Return vs Market: AVNS underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is AVNS's price volatile compared to industry and market?
AVNS volatility
AVNS Average Weekly Movement6.7%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: AVNS has not had significant price volatility in the past 3 months.

Volatility Over Time: AVNS's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20143,771Joe Woodyhttps://avanos.com

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems.

Avanos Medical, Inc. Fundamentals Summary

How do Avanos Medical's earnings and revenue compare to its market cap?
AVNS fundamental statistics
Market capUS$858.91m
Earnings (TTM)-US$9.90m
Revenue (TTM)US$673.30m

1.3x

P/S Ratio

-86.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AVNS income statement (TTM)
RevenueUS$673.30m
Cost of RevenueUS$293.60m
Gross ProfitUS$379.70m
Other ExpensesUS$389.60m
Earnings-US$9.90m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.23
Gross Margin56.39%
Net Profit Margin-1.47%
Debt/Equity Ratio13.6%

How did AVNS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.